BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24711076)

  • 21. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
    Johnson DA
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Luo JC; Huang KW; Leu HB; Chen LC; Hou MC; Li CP; Lu CL; Lin HC; Lee FY; Lee SD
    Aliment Pharmacol Ther; 2011 Sep; 34(5):519-25. PubMed ID: 21726257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
    Henriksen PA; Palmer K; Boon NA
    QJM; 2008 Apr; 101(4):261-7. PubMed ID: 18252776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of rebamipide on ammonia-induced gastric mucosal hemorrhagic lesion in rats.
    Huh K; Kwon TH; Kim SK; Kim JS; Shin US
    Arch Pharm Res; 1998 Feb; 21(1):1-5. PubMed ID: 9875506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet inhibition and gastric problems].
    Arnesen Ø; Riis JS
    Tidsskr Nor Laegeforen; 2007 Jan; 127(1):64; author reply 64. PubMed ID: 17205099
    [No Abstract]   [Full Text] [Related]  

  • 26. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
    Tsai TJ; Lai KH; Hsu PI; Lin CK; Chan HH; Yu HC; Wang HM; Lin KH; Wang KM; Chang SN; Liu CP; Hsiao SH; Huang HR; Lin CH; Tsay FW
    J Formos Med Assoc; 2012 Dec; 111(12):705-10. PubMed ID: 23265750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.
    Watanabe T; Takeuchi T; Handa O; Sakata Y; Tanigawa T; Shiba M; Naito Y; Higuchi K; Fujimoto K; Yoshikawa T; Arakawa T
    PLoS One; 2015; 10(4):e0122330. PubMed ID: 25874951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 30. [ASS or clopidogrel plus esomeprazole after bleeding from an ulcer].
    Nitschmann S; Mössner J
    Internist (Berl); 2005 Dec; 46(12):1405-8. PubMed ID: 16220275
    [No Abstract]   [Full Text] [Related]  

  • 31. Perioperative hemorrhage and combined clopidogrel and aspirin therapy.
    Moore M; Power M
    Anesthesiology; 2004 Sep; 101(3):792-4. PubMed ID: 15329606
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T; Ikee R; Miyasaka Y; Chubachi H; Saito S
    Yakugaku Zasshi; 2010 Dec; 130(12):1743-50. PubMed ID: 21139402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y; Suzuki H; Umetsu R; Uranishi H; Abe J; Nishibata Y; Sekiya Y; Miyamura N; Hara H; Tsuchiya T; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(5):680-6. PubMed ID: 25947914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease.
    Ng FH; Wong SY; Chang CM; Chen WH; Kng C; Lanas AI; Wong BC
    Aliment Pharmacol Ther; 2003 Aug; 18(4):443-9. PubMed ID: 12940930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: a prospective, randomized study involving 630 biopsies.
    Whitson MJ; Dikman AE; von Althann C; Sanyal S; Desai JC; Bamji ND; Kornacki S; Harpaz N; Bodian CA; Cohen LB; Miller KM; Aisenberg J
    J Clin Gastroenterol; 2011 Mar; 45(3):228-33. PubMed ID: 20717045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clopidogrel and PPI interaction: clinically relevant or not?
    Harrison RW; Mahaffey KW
    Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dilemma between gastroprotection and cardiovascular prevention].
    Venerito M; Kandulski A; Malfertheiner P
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel. Patients with peptic ulcers.
    Beales IL
    BMJ; 2009 May; 338():b1932. PubMed ID: 19457957
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial.
    Park SM; Jeong H; Jung MH; Hong KS; Hong MK; Bang CS; Kim CY
    Contemp Clin Trials; 2017 Sep; 60():51-55. PubMed ID: 28642210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.
    Huang KW; Luo JC; Leu HB; Huang CC; Hou MC; Chen TS; Lu CL; Lin HC; Lee FY; Chang FY
    J Chin Med Assoc; 2013 Jan; 76(1):9-14. PubMed ID: 23331775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.